Chronic allograft nephropathy
Chronic allograft nephropathy (CAN) is a kidney disorder which is the leading cause of kidney transplant failure,[1] occurring months to years after the transplant.
| Chronic allograft nephropathy | |
|---|---|
| Other names | Sclerosing/chronic allograft nephropathy |
 | |
| Micrograph of chronic allograft nephropathy. PAS stain. | |
| Specialty | Urology |
Symptoms and signs
CAN is characterized by a gradual decline in kidney function and, typically, accompanied by high blood pressure and hematuria.[2]
Pathology
The histopathology is characterized by interstitial fibrosis, tubular atrophy, fibrotic intimal thickening of arteries and glomerulosclerosis.[2][3]
Diagnosis
CAN is diagnosed by examination of tissue, e.g. a kidney biopsy.
References
- Paul, LC. (Sep 1999). "Chronic allograft nephropathy: An update". Kidney Int. 56 (3): 783–93. doi:10.1046/j.1523-1755.1999.00611.x. PMID 10469349.
- Joosten, SA.; Sijpkens, YW.; van Kooten, C.; Paul, LC. (Jul 2005). "Chronic renal allograft rejection: pathophysiologic considerations". Kidney Int. 68 (1): 1–13. doi:10.1111/j.1523-1755.2005.00376.x. PMID 15954891.
- Nankivell, BJ.; Chapman, JR. (Mar 2006). "Chronic allograft nephropathy: current concepts and future directions". Transplantation. 81 (5): 643–54. doi:10.1097/01.tp.0000190423.82154.01. PMID 16534463.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.